Response in the first year of anti-TNF treatment appears to be a strong predictor of whether people with SpA will stay on treatment in the long-term, an observational study suggests. The researchers from several rheumatology clinics in Greece say their findings suggest that close disease activity monitoring in the early years of treatment could be ...
SpA: Anti-TNF response in first year predicts long-term adherence
By Nicola Garrett
12 Apr 2018